Wall Street Isn't F...
Health Care: Drugs
Raptor Pharmaceutical Corp (RPTP: NASDAQ)
$5.37 0.06 | 1.13%
05/24/12 - 04:00 PM ET
219.74K / 280.80K
Vol / Avg. Vol:5.30 / 5.31
Open / Prev. Close:5.26 - 5.37
Today's Range:3.66 - 7.90
52 Wk Range:-15.18%
Performance YTD:TheStreet Rating:
Portfolios with RPTP
- Portfolio NameUser Type
- UserNew
- ContributorUnder-$10 Setting Up To Tra...
- ContributorEarnings Short Squeeze Play...
- ContributorBreakout Stocks Of The Week...
- UserTrashy77 - 20110803
- ContributorHeavily Shorted Market Lead...
- ContributorHot Biotech Trades for Seco...
- Contributor10 Health-Care Stocks Outpe...
- UserGladiador
Latest RPTP Headlines from TheStreet
- 26 Drugs Facing FDA Approval in 2012 05.02.12 | 01:05 pm
- 5 Stocks Under $10 Set to Trigger Big Moves 01.27.12 | 01:01 pm
- 5 Stocks Poised for Breakouts 09.16.11 | 02:09 pm
- Raptor Orphan Drug Study Succeeds 07.25.11 | 07:07 am
- 5 Heavily Shorted Market Leaders Set to Soar 07.15.11 | 07:07 am
- More Hot Biotech Trades for Second Half 2011 07.12.11 | 06:07 am
- Raptor Pharmaceutical To Enroll Five Additional Patients In Pivotal Phase 3 Clinical Trial Of DR Cysteamine For The Potential Treatment Of Nephropathic Cystinosis 02.15.11 | 06:02 am
- Raptor Pharmaceutical Completes Enrollment In Pivotal Phase 3 Clinical Trial Of DR Cysteamine For The Potential Treatment Of Nephropathic Cystinosis 01.24.11 | 06:01 am
- Raptor Pharmaceutical Hires Patrick Reichenberger To Lead Commercial Development Of DR Cysteamine For Nephropathic Cystinosis 01.10.11 | 06:01 am
- Raptor Pharmaceutical Commences Phase 2 Clinical Trial Of DR Cysteamine For The Potential Treatment Of Huntington's Disease 11.08.10 | 06:11 am
Press Releases for RPTP
Partner Headlines for RPTP
- Raptor Pharmaceutical Announces Publication of Phase 3 Results in the Clinical Journal of the American Society of Nephrology - Benzinga 05.03.12 | 01:05 pm
- Raptor Pharmaceutical Stockholder Meeting Adjourned due to Lack of Requisite Quorum - Benzinga 04.26.12 | 01:04 pm
- VIX - Options Volatility Sonar: Friday Recap - Seeking Alpha 03.09.12 | 04:03 pm
- Q3 Micro-Cap Biotech Picks By The World's Largest Fund Managers - Seeking Alpha 12.08.11 | 09:12 am
- Raptor Pharmaceuticals Provides Update On Lead Candidate: RP103 - Seeking Alpha 10.31.11 | 08:10 am
- 16 Micro-Cap Stocks Being Targeted By Short Sellers - Seeking Alpha 10.26.11 | 09:10 am
- 5 Healthcare Stocks of Interest This Week - Seeking Alpha 07.27.11 | 09:07 am
- Morning Market Losers - Benzinga 07.25.11 | 09:07 am
- Recap: Wednesday's Top Percentage Gainers and Losers - Benzinga 06.22.11 | 04:06 pm
- 16 Small Caps With Cash to Cover 1+ Years of Operating Expenses - Seeking Alpha 04.20.11 | 04:04 am
